Reviews

• Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis (Cochrane Review)
• Bisphosphonates for osteoporosis in people with cystic fibrosis (Cochrane Review)
• Blood transfusion for preventing stroke in people with sickle cell disease (Cochrane Review)
• Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis (Cochrane Review)
• Dietary advice for illness-related malnutrition in adults (Cochrane Review)
• Dietary interventions for phenylketonuria (Cochrane Review)
• Dietary treatment for familial hypercholesterolaemia (Cochrane Review)
• Drug therapies for reducing gastric acidity in people with cystic fibrosis (Cochrane Review)
• Drugs for preventing red blood cell dehydration in people with sickle cell disease (Cochrane Review)
• Elective versus symptomatic intravenous antibiotic therapy for cystic fibrosis (Cochrane Review)
• Enteral tube feeding for cystic fibrosis (Cochrane Review)
• Home intravenous antibiotics for cystic fibrosis (Cochrane Review)
• Hydroxyurea for sickle cell disease (Cochrane Review)
• Inhaled bronchodilators for acute chest syndrome in people with sickle cell disease (Cochrane Review)
• Inhaled corticosteroids for cystic fibrosis (Cochrane Review)
• Macrolide antibiotics for cystic fibrosis (Cochrane Review)
• Nebulised anti-pseudomonal antibiotics for cystic fibrosis (Cochrane Review)
• Nebulised hypertonic saline for cystic fibrosis (Cochrane Review)
• Neonatal screening for sickle cell disease (Cochrane Review)
• Newborn screening for cystic fibrosis (Cochrane Review)
• Non-invasive ventilation for cystic fibrosis (Cochrane Review)
• Omega-3 fatty acids (from fish oils) for cystic fibrosis (Cochrane Review)
• Once daily versus multiple daily dosing with intravenous aminoglycosides for cystic fibrosis (Cochrane Review)
• Oral calorie supplements for cystic fibrosis (Cochrane Review)
• Oral non-steroidal anti-inflammatory drug therapy for cystic fibrosis (Cochrane Review)
• Oral protein calorie supplementation for children with chronic disease (Cochrane Review)
• Oral steroids for cystic fibrosis (Cochrane Review)
• Physical training for cystic fibrosis (Cochrane Review)
• Preoperative blood transfusions for sickle cell disease (Cochrane Review)
• Prophylactic antibiotics for cystic fibrosis (Cochrane Review)
• Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease (Cochrane Review)
• Psychological interventions for cystic fibrosis (Cochrane Review)
• Psychological therapies for sickle cell disease and pain (Cochrane Review)
• Psychological therapies for thalassaemia (Cochrane Review)
• Recombinant human deoxyribonuclease for cystic fibrosis (Cochrane Review)
• Single versus combination intravenous antibiotic therapy for people with cystic fibrosis (Cochrane Review)
• Splenectomy versus conservative management for acute sequestration crises in people with sickle cell disease (Cochrane Review)
• Totally implantable vascular access devices for cystic fibrosis (Cochrane Review)
• Tyrosine supplementation for phenylketonuria (Cochrane Review)
• Ursodeoxycholic acid for cystic fibrosis-related liver disease (Cochrane Review)
• Vaccines for preventing infection with Pseudomonas aeruginosa in people with cystic fibrosis (Cochrane Review)
• Vaccines for preventing influenza in people with cystic fibrosis (Cochrane Review)

Protocols

• Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis (Cochrane Protocol)
• CFTR gene transfer for lung disease in people with cystic fibrosis (Cochrane Protocol)
• Clotting factor concentrates given to prevent bleeding and bleeding related complications in people with hemophilia A and B (Cochrane Protocol)
• Conventional chest physiotherapy compared to other forms of chest physiotherapy for cystic fibrosis (Cochrane Protocol)
• Inhaled bronchodilators for cystic fibrosis (Cochrane Protocol)
• Oxygen therapy for cystic fibrosis (Cochrane Protocol)
• Pneumococcal vaccines for sickle cell disease (Cochrane Protocol)
• Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis (Cochrane Protocol)
• Treatment for avascular necrosis of bone in people with sickle cell disease (Cochrane Protocol)
• Treatments for priapism in boys and men with sickle cell disease (Cochrane Protocol)